Evaluation of congested area of the liver using a fluorescence imaging system

Evaluation of congested area of the liver using a fluorescence imaging system - Evaluation of congested area of the liver using a fluorescence imaging system

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003465

Enrollment

Registered

2011-04-01

Start date

2010-04-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver cancer, donor of the LDLT

Interventions

evaluation of the congested area after the injection of ICG using fluorescent imaging system.ICG dose of 1mg is injected intravenouly during operation.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Cases of hepatectomy concnmitant with major hepatic veins, scheduled for the treatment of liver cancer or donor of the LDLT in our department

Exclusion criteria

Exclusion criteria: If the patient has the history of severe allergy for ICG, If the patients do not agree, the patients will be excluded from this study

Design outcomes

Primary

Measure	Time frame
congested area	—

Countries

Japan

Contacts

Public ContactAkira Kobayashi

Shinshu University School of Medicine Gastrointestinal Surgery

kbys@shinshu-u.ac.jp0263-37-2654

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026